Major shareholder announcement

Company announcement          Orphazyme A/SNo. 09/2023       Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.comCompany Registration No. 32266355 Major shareholder announcement Copenhagen, Denmark, May 17 , 2023 –Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from MH Investment ApS, that as of May 16, 2023, MH Investment ApS holds shares corresponding to 10...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Company announcement        

Orphazyme A/S
No. 09/2023       

Ole Maaløes Vej 3
DK-2200 Copenhagen N

www.orphazyme.com
Company Registration No. 32266355

Major shareholder announcement

Copenhagen, Denmark, May 17, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from MH Investment ApS, that as of May 16, 2023, MH Investment ApS holds shares corresponding to 10.00% of the total share capital and voting rights in the Company.

For additional information, please contact

Orphazyme A/S

Michael Hove, Chairman of the board +45 28 12 66 09

Attachment

  • Orphazyme - Company announcement - Major shareholder announcement

Per maggiori informazioni
Sito Web
orphazyme.com

Ufficio Stampa

 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti

Allegati
Slide ShowSlide Show
Non disponibili
;